Subscribe Now Subscribe Today
Research Article
 

Effects of Aspirin and Celecoxib on Rigidity in a Rat Model of Parkinson`s Disease



Hadi Fathi Moghaddam , Aliasghar Hemmati , Zahra Nazari , Hasan Mehrab , Khosro M. Abid and Mehdi Shafiee Ardestani
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

Parkinson`s disease (PD) is a degenerative neurodopaminergic disease in nigrostriatum pathway of human and is responsible for most of the movement disorders. Increasing evidence suggests that an inflammatory reaction accompanies the pathological processes caused by Cyclooxygenase (COX) seen in many neurodegenerative disorders, including PD and according to the recent researches chronic use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) decreases the risk of PD in human. In the study the rat left Substantia Nigra Pars Compacta (SNc) have been destroyed using electrical lesion (1 mA; DC; 8 Sec) to induce PD model. Then aspirin (30, 60 mg kg-1) and celecoxib (4, 8 mg kg-1) have been administrated orally to parkinsonian rats. When the animals were suffered to PD Murprogo`s Method evaluated the rigidity of parkinsonian rats. Both selective COX-2 inhibitor (celecoxib) and non-selective COX-2 inhibitor (aspirin) decreased the rigidity of parkinsonian rats p< 0.05 but rigidity recovery after administration the selective COX-2 inhibitor was more than non-selective COX-2 inhibitor. These findings are additional pharmacological information which has suggested the use of NSAIDs as alternative way to treat the rigidity of PD.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Hadi Fathi Moghaddam , Aliasghar Hemmati , Zahra Nazari , Hasan Mehrab , Khosro M. Abid and Mehdi Shafiee Ardestani , 2007. Effects of Aspirin and Celecoxib on Rigidity in a Rat Model of Parkinson`s Disease . Pakistan Journal of Biological Sciences, 10: 3853-3858.

DOI: 10.3923/pjbs.2007.3853.3858

URL: https://scialert.net/abstract/?doi=pjbs.2007.3853.3858

REFERENCES
1:  Asanuma, M., I. Miyazaki, T. Tsuji and N. Ogawa, 2003. New aspects of neuroprotective effects of nonsteroidal anti-inflammatory drugs. Nihon Shinkei Seishin Yakurigaku Zasshi, 23: 111-119.
Direct Link  |  

2:  Bal-Price, A. and G.C. Brown, 2001. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci., 21: 6480-6491.
Direct Link  |  

3:  Banati, R.B., G.W. Goerres, R. Myers, R.N. Gunn and F.E. Turkheimer et al., 1999. [11C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology, 53: 2199-2203.
Direct Link  |  

4:  Buccafusco, J.J., C.A. Lapp, R.S. Aronstam and A.C. Hays, 1993. Role of prostanoids in the regulation of central cholinergic receptor sensitivity. J. Pharmacol. Exp. Ther., 266: 314-322.

5:  Casper, D., U. Yaparpalvi, N. Rempel and P. Wener, 2000. Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro. Neurosci. Lett., 289: 201-204.
CrossRef  |  Direct Link  |  

6:  Dubois, R.N., S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B.V.D. Putte and P.E. Lipsky, 1998. Cyclooxygenase in biology and disease. FASEB J., 12: 1063-1073.
CrossRef  |  PubMed  |  Direct Link  |  

7:  Etminan, M., S.S. Gill and A. Samii, 2002. Intake of vitamin E, vitamin C and carotenoids and the risk of Parkinson's disease: A meta-analysis. Lancet Neurol., 4: 362-365.
CrossRef  |  Direct Link  |  

8:  Gao, H.M., J. Jiang, B. Wilson, W. Zhang, J.S. Hong and B. Liu, 2002. Microglial activation mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: Relevance to Parkinson's disease. J. Neurochem., 81: 1285-1297.
PubMed  |  Direct Link  |  

9:  Herschman, H.R., 1996. Prostaglandin synthase-2. Biochem. Biophys. Acta, 1299: 153-179.
PubMed  |  Direct Link  |  

10:  Hirsch, E.C., S. Hunot, P. Damier and B. Faucheux, 1998. Glial cells and inflammation in Parkinson's disease: A role in neurodegeneration. Ann. Neurol., 44: S115-S120.
Direct Link  |  

11:  Ito, Y., 1982. Modulatory actions of prostaglandins in autonomic neuro-effector transmissions. Nippon Yakurigako Zasshi, 79: 1-14.
PubMed  |  Direct Link  |  

12:  Katzung, B.G., 2004. Basic and Clinical Pharmacology. Williams and Wilkins, New York, pp: 298-311.

13:  King, D., J.R. Playfer and N.B. Roberts, 1992. Concentrations of vitamins A, C and E in elderly patients with Parkinson's disease. Postgrad. Med. J., 68: 634-637.
PubMed  |  Direct Link  |  

14:  Li, R.C., B.W. Row, E. Gozal, Q. Fan and S.Z. Guo, 2003. Cyclooxygenase-2 and intermittent hypoxia-induced spatial defects in the rat. Am. J. Respir. Crit. Care Med., 168: 469-475.

15:  McGeer, P.L. and E.G. McGeer, 2002. Innate immunity, local inflammation and degenerative disease. Sci. Aging Knowledge Environ., 2002: re3-re3.
CrossRef  |  Direct Link  |  

16:  McGeer, P.L., C. Schwab, A. Parent and D. Doudet, 2003. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administration. Ann. Neurol., 54: 599-604.
PubMed  |  Direct Link  |  

17:  Minghetti, L., 2004. Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J. Neuropathol. Exp. Neural., 63: 901-910.
PubMed  |  

18:  Mladenovic, A., M. Perovic, N. Raicevic, S. Kanazir, L. Rakic and S. Ruzdijic, 2004. 6-Hydroxydopamine increases the level of TNFalpha and bax mRNA in the striatum and induces apoptosis of dopaminergic neurons in hemiparkinsonian rats. Brain Res., 996: 237-245.
PubMed  |  Direct Link  |  

19:  Murprogo, C., 1962. Effect of Antiparkinson Drug on a Phenothiazine Induced Catatonia Reaction. Arc. Int. Pharma. Co. Dyn., 137: 48-90.
PubMed  |  Direct Link  |  

20:  Paxinos, G. and C. Watson, 1997. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.

21:  Rall, J.M., S.A. Mach and P.K. Dash, 2003. Intrahippocampal infusion cyclooxygenase-2 inhibitor attenuates memory acquisition in rats. Brain Res., 968: 273-276.
CrossRef  |  Direct Link  |  

22:  Riechman, W. and L.E. Hokin, 1987. Acetylcholine releases prostaglandins from brain slices incubated in vitro. J. Neurochem., 49: 1261-1261.
PubMed  |  Direct Link  |  

23:  Sanchez-Pernaute, R., A. Ferree, O. Cooper, M. Yu, A.L. Brownell and O. Isacson, 2004. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J. Neuroinflammation, 1: 6-6.
CrossRef  |  PubMed  |  Direct Link  |  

24:  Shaftel, S.S., J.A. Olschowka and S.D. Hurly, 2003. COX-3: A splice variant of cyclooxygenase-1 in mouse neural tissue and cells. Brain Res., Mol. Brain Res., 119: 213-215.
CrossRef  |  

25:  Sharifzadeh, M., M. Tavasoli, N. Naghdi, A. Ghanbari, M. Amini and A. Roghani, 2005. Post-training intrahippocampal infusion of nicotine prevents spatial memory retention deficits induced by the cyclo-oxygenase-2-specific inhibitor celecoxib in rats. J. Neurochem., 95: 1078-1090.
PubMed  |  Direct Link  |  

26:  Smith, W.L., L.J. Marnett and D.L. Dewitt, 1991. Prostaglandin and thromboxane biosynthesis. Pharmacol. Ther., 49: 153-179.
Direct Link  |  

27:  Teismann, P. and B. Ferger, 2001. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease. Synapse, 39: 167-174.
PubMed  |  Direct Link  |  

28:  Teismann, P., K. Tieu, D.K. Choi, D.C. Wu and A. Naini et al., 2003. Cyclooxygenase-2 is instrument in Parkinson`s Disease neurodegeneration. Proc. Natl. Acad. Sci. USA., 100: 5473-5478.
CrossRef  |  PubMed  |  

29:  Wu, D.C., V. Jackson-Lewis, M. Vila, K. Tieu and P. Teismann et al., 2002. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson disease. J. Neurosci., 22: 1763-1771.
PubMed  |  Direct Link  |  

30:  Xie, W., J.G. Chipman, D.L. Robertson, A.R. Erikson and D.L. Simmons, 1991. Expression of a mitogen responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci., 88: 2692-2696.
PubMed  |  Direct Link  |  

31:  Yamagata, K., K.I. Andreasson, W.E. Kaufmann, C.A. Barnes and P.F. Worley, 1993. Expression of a mitogen-inducible cyclooxygenase in brain neurons: Regulation by Synaptic Activity and Glucocorticoids. Neuron, 11: 371-386.
CrossRef  |  PubMed  |  Direct Link  |  

©  2021 Science Alert. All Rights Reserved